AARP WILL LOOK AT PHARMACY BENEFIT MANAGEMENT APPROACH FOR MEDICARE DRUG PLAN; REPS. WAXMAN AND WYDEN INTERESTED; GLAXO POSITION MAY HERALD COMMON GROUND
The American Association of Retired Persons will examine the pharmacy benefit management plans being suggested as alternatives to a government-run outpatient drug program for Medicare beneficiaries, the lobby group for the elderly told the House Energy & Commerce/Health Subcommittee at a Feb. 8 hearing.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth